Martingale Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,304
| Closed | -$158K | – | 844 |
|
|
2024
Q3 | $158K | Hold |
11,304
| – | – | ﹤0.01% | 775 |
|
|
2024
Q2 | $92.9K | Buy |
+11,304
| New | +$92.9K | ﹤0.01% | 779 |
|
|
2023
Q4 | – | Sell |
-20,203
| Closed | -$181K | – | 850 |
|
|
2023
Q3 | $181K | Sell |
20,203
-24,800
| -55% | -$222K | ﹤0.01% | 755 |
|
|
2023
Q2 | $691K | Sell |
45,003
-4,700
| -9% | -$72.2K | 0.01% | 536 |
|
|
2023
Q1 | $1.12M | Buy |
49,703
+200
| +0.4% | +$4.5K | 0.02% | 418 |
|
|
2022
Q4 | $1.04M | Buy |
49,503
+10,988
| +29% | +$231K | 0.02% | 439 |
|
|
2022
Q3 | $950K | Buy |
38,515
+23,315
| +153% | +$575K | 0.02% | 456 |
|
|
2022
Q2 | $369K | Buy |
+15,200
| New | +$369K | 0.01% | 706 |
|
|
2021
Q2 | – | Sell |
-18,615
| Closed | -$465K | – | 899 |
|
|
2021
Q1 | $465K | Sell |
18,615
-1,400
| -7% | -$35K | 0.01% | 628 |
|
|
2020
Q4 | $547K | Sell |
20,015
-75,800
| -79% | -$2.07M | 0.01% | 592 |
|
|
2020
Q3 | $1.77M | Sell |
95,815
-95,500
| -50% | -$1.76M | 0.02% | 454 |
|
|
2020
Q2 | $3.91M | Buy |
+191,315
| New | +$3.91M | 0.05% | 364 |
|